Cargando…

Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of kidney failure. Patients with glome...

Descripción completa

Detalles Bibliográficos
Autores principales: Caravaca-Fontán, Fernando, Cavero, Teresa, Díaz-Encarnación, Montserrat, Cabello, Virginia, Ariceta, Gema, Quintana, Luis F., Marco, Helena, Barros, Xoana, Ramos, Natalia, Rodríguez-Mendiola, Nuria, Cruz, Sonia, Fernández-Juárez, Gema, Rodríguez, Adela, Pérez de José, Ana, Rabasco, Cristina, Rodado, Raquel, Fernández, Loreto, Pérez-Gómez, Vanessa, Ávila, Ana, Bravo, Luis, Espinosa, Natalia, Allende, Natalia, Sanchez de la Nieta, Maria Dolores, Rodríguez, Eva, Rivas, Begoña, Melgosa, Marta, Huerta, Ana, Miquel, Rosa, Mon, Carmen, Fraga, Gloria, de Lorenzo, Alberto, Draibe, Juliana, González, Fayna, Shabaka, Amir, López-Rubio, Maria Esperanza, Fenollosa, María Ángeles, Martín-Penagos, Luis, Da Silva, Iara, Titos, Juana Alonso, Rodríguez de Córdoba, Santiago, Goicoechea de Jorge, Elena, Praga, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278771/
https://www.ncbi.nlm.nih.gov/pubmed/36996481
http://dx.doi.org/10.34067/KID.0000000000000115
_version_ 1785060547993010176
author Caravaca-Fontán, Fernando
Cavero, Teresa
Díaz-Encarnación, Montserrat
Cabello, Virginia
Ariceta, Gema
Quintana, Luis F.
Marco, Helena
Barros, Xoana
Ramos, Natalia
Rodríguez-Mendiola, Nuria
Cruz, Sonia
Fernández-Juárez, Gema
Rodríguez, Adela
Pérez de José, Ana
Rabasco, Cristina
Rodado, Raquel
Fernández, Loreto
Pérez-Gómez, Vanessa
Ávila, Ana
Bravo, Luis
Espinosa, Natalia
Allende, Natalia
Sanchez de la Nieta, Maria Dolores
Rodríguez, Eva
Rivas, Begoña
Melgosa, Marta
Huerta, Ana
Miquel, Rosa
Mon, Carmen
Fraga, Gloria
de Lorenzo, Alberto
Draibe, Juliana
González, Fayna
Shabaka, Amir
López-Rubio, Maria Esperanza
Fenollosa, María Ángeles
Martín-Penagos, Luis
Da Silva, Iara
Titos, Juana Alonso
Rodríguez de Córdoba, Santiago
Goicoechea de Jorge, Elena
Praga, Manuel
author_facet Caravaca-Fontán, Fernando
Cavero, Teresa
Díaz-Encarnación, Montserrat
Cabello, Virginia
Ariceta, Gema
Quintana, Luis F.
Marco, Helena
Barros, Xoana
Ramos, Natalia
Rodríguez-Mendiola, Nuria
Cruz, Sonia
Fernández-Juárez, Gema
Rodríguez, Adela
Pérez de José, Ana
Rabasco, Cristina
Rodado, Raquel
Fernández, Loreto
Pérez-Gómez, Vanessa
Ávila, Ana
Bravo, Luis
Espinosa, Natalia
Allende, Natalia
Sanchez de la Nieta, Maria Dolores
Rodríguez, Eva
Rivas, Begoña
Melgosa, Marta
Huerta, Ana
Miquel, Rosa
Mon, Carmen
Fraga, Gloria
de Lorenzo, Alberto
Draibe, Juliana
González, Fayna
Shabaka, Amir
López-Rubio, Maria Esperanza
Fenollosa, María Ángeles
Martín-Penagos, Luis
Da Silva, Iara
Titos, Juana Alonso
Rodríguez de Córdoba, Santiago
Goicoechea de Jorge, Elena
Praga, Manuel
author_sort Caravaca-Fontán, Fernando
collection PubMed
description KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of kidney failure. Patients with glomerulopathy with a progressive reduction in proteinuria over time did not reach kidney failure. BACKGROUND: C3 glomerulopathy is a rare kidney disease, which makes it difficult to collect large cohorts of patients to better understand its variability. The aims of this study were to describe the clinical profiles and patterns of progression of kidney disease. METHODS: This was a retrospective, observational cohort study. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. Study population was divided into clinical profiles by combining the following predictors: eGFR under/above 30 ml/min per 1.73 m(2), proteinuria under/above 3.5 g/d, and histologic chronicity score under/above 4. The change in eGFR and proteinuria over time was evaluated in a subgroup with consecutive measurements of eGFR and proteinuria. RESULTS: One hundred and fifteen patients with a median age of 30 years (interquartile range 19–50) were included. Patients were divided into eight clinical profiles. Kidney survival was significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d, both in those presenting with an eGFR under/above 30 ml/min per 1.73 m(2). The median eGFR slope of patients who reached kidney failure was −6.5 ml/min per 1.73 m(2) per year (interquartile range −1.6 to −17). Patients who showed a reduction in proteinuria over time did not reach kidney failure. On the basis of the rate of eGFR decline, patients were classified as faster eGFR decline (≥5 ml/min per 1.73 m(2) per year), slower (<5 ml/min per 1.73 m(2) per year), and those without decline. A faster eGFR decline was associated with higher probability of kidney failure. CONCLUSIONS: Kidney survival is significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d regardless of baseline eGFR, and a faster rate of decline in eGFR is associated with higher probability of kidney failure.
format Online
Article
Text
id pubmed-10278771
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society of Nephrology
record_format MEDLINE/PubMed
spelling pubmed-102787712023-08-03 Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy Caravaca-Fontán, Fernando Cavero, Teresa Díaz-Encarnación, Montserrat Cabello, Virginia Ariceta, Gema Quintana, Luis F. Marco, Helena Barros, Xoana Ramos, Natalia Rodríguez-Mendiola, Nuria Cruz, Sonia Fernández-Juárez, Gema Rodríguez, Adela Pérez de José, Ana Rabasco, Cristina Rodado, Raquel Fernández, Loreto Pérez-Gómez, Vanessa Ávila, Ana Bravo, Luis Espinosa, Natalia Allende, Natalia Sanchez de la Nieta, Maria Dolores Rodríguez, Eva Rivas, Begoña Melgosa, Marta Huerta, Ana Miquel, Rosa Mon, Carmen Fraga, Gloria de Lorenzo, Alberto Draibe, Juliana González, Fayna Shabaka, Amir López-Rubio, Maria Esperanza Fenollosa, María Ángeles Martín-Penagos, Luis Da Silva, Iara Titos, Juana Alonso Rodríguez de Córdoba, Santiago Goicoechea de Jorge, Elena Praga, Manuel Kidney360 Original Investigation KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of kidney failure. Patients with glomerulopathy with a progressive reduction in proteinuria over time did not reach kidney failure. BACKGROUND: C3 glomerulopathy is a rare kidney disease, which makes it difficult to collect large cohorts of patients to better understand its variability. The aims of this study were to describe the clinical profiles and patterns of progression of kidney disease. METHODS: This was a retrospective, observational cohort study. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. Study population was divided into clinical profiles by combining the following predictors: eGFR under/above 30 ml/min per 1.73 m(2), proteinuria under/above 3.5 g/d, and histologic chronicity score under/above 4. The change in eGFR and proteinuria over time was evaluated in a subgroup with consecutive measurements of eGFR and proteinuria. RESULTS: One hundred and fifteen patients with a median age of 30 years (interquartile range 19–50) were included. Patients were divided into eight clinical profiles. Kidney survival was significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d, both in those presenting with an eGFR under/above 30 ml/min per 1.73 m(2). The median eGFR slope of patients who reached kidney failure was −6.5 ml/min per 1.73 m(2) per year (interquartile range −1.6 to −17). Patients who showed a reduction in proteinuria over time did not reach kidney failure. On the basis of the rate of eGFR decline, patients were classified as faster eGFR decline (≥5 ml/min per 1.73 m(2) per year), slower (<5 ml/min per 1.73 m(2) per year), and those without decline. A faster eGFR decline was associated with higher probability of kidney failure. CONCLUSIONS: Kidney survival is significantly higher in patients with a chronicity score <4 and proteinuria <3.5 g/d regardless of baseline eGFR, and a faster rate of decline in eGFR is associated with higher probability of kidney failure. American Society of Nephrology 2023-03-30 /pmc/articles/PMC10278771/ /pubmed/36996481 http://dx.doi.org/10.34067/KID.0000000000000115 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Caravaca-Fontán, Fernando
Cavero, Teresa
Díaz-Encarnación, Montserrat
Cabello, Virginia
Ariceta, Gema
Quintana, Luis F.
Marco, Helena
Barros, Xoana
Ramos, Natalia
Rodríguez-Mendiola, Nuria
Cruz, Sonia
Fernández-Juárez, Gema
Rodríguez, Adela
Pérez de José, Ana
Rabasco, Cristina
Rodado, Raquel
Fernández, Loreto
Pérez-Gómez, Vanessa
Ávila, Ana
Bravo, Luis
Espinosa, Natalia
Allende, Natalia
Sanchez de la Nieta, Maria Dolores
Rodríguez, Eva
Rivas, Begoña
Melgosa, Marta
Huerta, Ana
Miquel, Rosa
Mon, Carmen
Fraga, Gloria
de Lorenzo, Alberto
Draibe, Juliana
González, Fayna
Shabaka, Amir
López-Rubio, Maria Esperanza
Fenollosa, María Ángeles
Martín-Penagos, Luis
Da Silva, Iara
Titos, Juana Alonso
Rodríguez de Córdoba, Santiago
Goicoechea de Jorge, Elena
Praga, Manuel
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
title Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
title_full Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
title_fullStr Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
title_full_unstemmed Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
title_short Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
title_sort clinical profiles and patterns of kidney disease progression in c3 glomerulopathy
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278771/
https://www.ncbi.nlm.nih.gov/pubmed/36996481
http://dx.doi.org/10.34067/KID.0000000000000115
work_keys_str_mv AT caravacafontanfernando clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT caveroteresa clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT diazencarnacionmontserrat clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT cabellovirginia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT aricetagema clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT quintanaluisf clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT marcohelena clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT barrosxoana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT ramosnatalia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT rodriguezmendiolanuria clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT cruzsonia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT fernandezjuarezgema clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT rodriguezadela clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT perezdejoseana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT rabascocristina clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT rodadoraquel clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT fernandezloreto clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT perezgomezvanessa clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT avilaana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT bravoluis clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT espinosanatalia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT allendenatalia clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT sanchezdelanietamariadolores clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT rodriguezeva clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT rivasbegona clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT melgosamarta clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT huertaana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT miquelrosa clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT moncarmen clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT fragagloria clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT delorenzoalberto clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT draibejuliana clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT gonzalezfayna clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT shabakaamir clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT lopezrubiomariaesperanza clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT fenollosamariaangeles clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT martinpenagosluis clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT dasilvaiara clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT titosjuanaalonso clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT rodriguezdecordobasantiago clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT goicoecheadejorgeelena clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy
AT pragamanuel clinicalprofilesandpatternsofkidneydiseaseprogressioninc3glomerulopathy